TY  - CHAP
M1  - Book, Section
TI  - Chapter 120. Rheumatoid Arthritis and Other Autoimmune Diseases
A1  - Yung, Raymond
A2  - Halter, Jeffrey B.
A2  - Ouslander, Joseph G.
A2  - Tinetti, Mary E.
A2  - Studenski, Stephanie
A2  - High, Kevin P.
A2  - Asthana, Sanjay
PY  - 2009
T2  - Hazzard's Geriatric Medicine and Gerontology, 6e
AB  - Our  understanding  of  the  pathogenesis  and  approach  to  treatment  of  autoimmune  diseases  continue  to  evolve.  However,  key  questions  concerning  the  epidemiology,  pathogenesis  and  optimal  treatment  of  these  diseases  in  the  elderly  population  remain  unanswered.  Despite  the  many  exciting  new  therapeutic  advances,  immunosuppression  in  elderly  patients  with  autoimmune  diseases  continues  to  pose  a  dilemma.  Changing  population  demographics  and  the  advent  of  biologics,  coupled  with  the  lack  of  the  availability  of  a  rheumatologist  in  many  smaller  communities,  will  significantly  impact  the  geriatrician's  role  in  the  care  of  older  adults  with  autoimmune  diseases  in  the  coming  years.  This  chapter  summarizes  key  recent  advances,  with  specific  references  to  the  geriatric  population.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2022/05/23
UR  - accessmedicine.mhmedical.com/content.aspx?aid=5135755
ER  -